BACKGROUND: Populations in South and East Asia and many other regions of the world are chronically exposed to arsenic-contaminated drinking water. To various degrees, ingested inorganic arsenic (InAs) is methylated to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) via folate-dependent one-carbon metabolism; impaired methylation is associated with adverse health outcomes. Consequently, folate nutritional status may influence arsenic methylation and toxicity. OBJECTIVE: The objective of this study was to test the hypothesis that folic acid supplementation of arsenic-exposed adults would increase arsenic methylation. DESIGN:Two hundred adults in a rural region of Bangladesh, previously found to have low plasma concentrations of folate (</=9 nmol/L) were enrolled in a randomized, double-blind, placebo-controlled folic acid-supplementation trial. Plasma concentrations of folate and homocysteine and urinary concentrations of arsenic metabolites were analyzed at baseline and after 12 wk of supplementation with folic acid at a dose of 400 microg/d or placebo. RESULTS: The increase in the proportion of total urinary arsenic excreted as DMA in the folic acid group (72% before and 79% after supplementation) was significantly (P < 0.0001) greater than that in the placebo group, as was the reduction in the proportions of total urinary arsenic excreted as MMA (13% and 10%, respectively; P < 0.0001) and as InAs (15% and 11%, respectively; P < 0.001). CONCLUSIONS: These data indicate that folic acid supplementation to participants with low plasma folate enhances arsenic methylation. Because persons whose urine contains low proportions of DMA and high proportions of MMA and InAs have been reported to be at greater risk of skin and bladder cancers and peripheral vascular disease, these results suggest that folic acid supplementation may reduce the risk of arsenic-related health outcomes.
RCT Entities:
BACKGROUND: Populations in South and East Asia and many other regions of the world are chronically exposed to arsenic-contaminated drinking water. To various degrees, ingested inorganic arsenic (InAs) is methylated to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) via folate-dependent one-carbon metabolism; impaired methylation is associated with adverse health outcomes. Consequently, folate nutritional status may influence arsenic methylation and toxicity. OBJECTIVE: The objective of this study was to test the hypothesis that folic acid supplementation of arsenic-exposed adults would increase arsenic methylation. DESIGN: Two hundred adults in a rural region of Bangladesh, previously found to have low plasma concentrations of folate (</=9 nmol/L) were enrolled in a randomized, double-blind, placebo-controlled folic acid-supplementation trial. Plasma concentrations of folate and homocysteine and urinary concentrations of arsenic metabolites were analyzed at baseline and after 12 wk of supplementation with folic acid at a dose of 400 microg/d or placebo. RESULTS: The increase in the proportion of total urinary arsenic excreted asDMA in the folic acid group (72% before and 79% after supplementation) was significantly (P < 0.0001) greater than that in the placebo group, as was the reduction in the proportions of total urinary arsenic excreted asMMA (13% and 10%, respectively; P < 0.0001) and as InAs (15% and 11%, respectively; P < 0.001). CONCLUSIONS: These data indicate that folic acid supplementation to participants with low plasma folate enhances arsenic methylation. Because persons whose urine contains low proportions of DMA and high proportions of MMA and InAs have been reported to be at greater risk of skin and bladder cancers and peripheral vascular disease, these results suggest that folic acid supplementation may reduce the risk of arsenic-related health outcomes.
Authors: R A Zakharyan; A Sampayo-Reyes; S M Healy; G Tsaprailis; P G Board; D C Liebler; H V Aposhian Journal: Chem Res Toxicol Date: 2001-08 Impact factor: 3.739
Authors: Soma R Mitra; D N Guha Mazumder; Arindam Basu; Gladys Block; Reina Haque; Sambit Samanta; Nilima Ghosh; Meera M Hira Smith; Ondine S von Ehrenstein; Allan H Smith Journal: Environ Health Perspect Date: 2004-07 Impact factor: 9.031
Authors: Margaret R Karagas; Tracy Punshon; Matt Davis; Catherine M Bulka; Francis Slaughter; Despina Karalis; Maria Argos; Habibul Ahsan Journal: Curr Environ Health Rep Date: 2019-12
Authors: Megan N Hall; Caitlin G Howe; Xinhua Liu; Marie A Caudill; Olga Malysheva; Vesna Ilievski; Angela M Lomax-Luu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad N Uddin; Tariqul Islam; Joseph H Graziano; Mary V Gamble Journal: J Nutr Date: 2016-04-06 Impact factor: 4.798
Authors: Catherine W Yeckel; Kathleen M McCarty; Elyssa R Gelmann; Eugen Gurzau; Anca Gurzau; Walter Goessler; Julie Kunrath Journal: Environ Toxicol Pharmacol Date: 2013-10-19 Impact factor: 4.860
Authors: Lizbeth López-Carrillo; Brenda Gamboa-Loira; Wendy Becerra; César Hernández-Alcaraz; Raúl Ulises Hernández-Ramírez; A Jay Gandolfi; Francisco Franco-Marina; Mariano E Cebrián Journal: Environ Res Date: 2016-08-23 Impact factor: 6.498
Authors: Matilda O Johnson; Hari H P Cohly; Raphael D Isokpehi; Omotayo R Awofolu Journal: Int J Environ Res Public Health Date: 2010-04-28 Impact factor: 3.390
Authors: J Richard Pilsner; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2008-09-26 Impact factor: 9.031
Authors: Megan N Hall; Xinhua Liu; Vesna Slavkovich; Vesna Ilievski; J Richard Pilsner; Shafiul Alam; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2009-01-15 Impact factor: 9.031